China · Delayed Price · Currency is CNY TECON BIOLOGY Co.LTD Statistics
Total Valuation
SHE:002100 has a market cap or net worth of CNY 8.22 billion. The enterprise value is 13.16 billion.
| Market Cap | 8.22B |
| Enterprise Value | 13.16B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jun 10, 2026 |
Share Statistics
SHE:002100 has 1.37 billion shares outstanding. The number of shares has increased by 2.46% in one year.
| Current Share Class | 1.37B |
| Shares Outstanding | 1.37B |
| Shares Change (YoY) | +2.46% |
| Shares Change (QoQ) | -9.25% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 12.81% |
| Float | 867.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 357.34 |
| PS Ratio | 0.49 |
| PB Ratio | 0.97 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | 12.73 |
| P/OCF Ratio | 8.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.94, with an EV/FCF ratio of 20.37.
| EV / Earnings | n/a |
| EV / Sales | 0.79 |
| EV / EBITDA | 13.94 |
| EV / EBIT | 99.35 |
| EV / FCF | 20.37 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.78.
| Current Ratio | 1.63 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 7.00 |
| Debt / FCF | 10.24 |
| Interest Coverage | 0.85 |
Financial Efficiency
Return on equity (ROE) is -0.51% and return on invested capital (ROIC) is 1.09%.
| Return on Equity (ROE) | -0.51% |
| Return on Assets (ROA) | 0.46% |
| Return on Invested Capital (ROIC) | 1.09% |
| Return on Capital Employed (ROCE) | 1.16% |
| Weighted Average Cost of Capital (WACC) | 4.90% |
| Revenue Per Employee | 3.48M |
| Profits Per Employee | -20,985 |
| Employee Count | 4,803 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 3.01 |
Taxes
In the past 12 months, SHE:002100 has paid 35.53 million in taxes.
| Income Tax | 35.53M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.28% in the last 52 weeks. The beta is 0.56, so SHE:002100's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -2.28% |
| 50-Day Moving Average | 7.19 |
| 200-Day Moving Average | 7.26 |
| Relative Strength Index (RSI) | 28.45 |
| Average Volume (20 Days) | 18,642,139 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002100 had revenue of CNY 16.72 billion and -100.79 million in losses. Loss per share was -0.07.
| Revenue | 16.72B |
| Gross Profit | 1.29B |
| Operating Income | 132.42M |
| Pretax Income | -8.11M |
| Net Income | -100.79M |
| EBITDA | 771.51M |
| EBIT | 132.42M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 3.26 billion in cash and 6.61 billion in debt, with a net cash position of -3.35 billion or -2.46 per share.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 6.61B |
| Net Cash | -3.35B |
| Net Cash Per Share | -2.46 |
| Equity (Book Value) | 8.44B |
| Book Value Per Share | 5.02 |
| Working Capital | 4.19B |
Cash Flow
In the last 12 months, operating cash flow was 988.19 million and capital expenditures -342.48 million, giving a free cash flow of 645.71 million.
| Operating Cash Flow | 988.19M |
| Capital Expenditures | -342.48M |
| Depreciation & Amortization | 639.09M |
| Net Borrowing | -45.15M |
| Free Cash Flow | 645.71M |
| FCF Per Share | 0.47 |
Margins
Gross margin is 7.70%, with operating and profit margins of 0.79% and -0.60%.
| Gross Margin | 7.70% |
| Operating Margin | 0.79% |
| Pretax Margin | -0.05% |
| Profit Margin | -0.60% |
| EBITDA Margin | 4.61% |
| EBIT Margin | 0.79% |
| FCF Margin | 3.86% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 1.30%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 1.30% |
| Dividend Growth (YoY) | -64.55% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.46% |
| Shareholder Yield | -1.16% |
| Earnings Yield | -1.23% |
| FCF Yield | 7.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SHE:002100 is 8.23, which is 37.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 8.23 |
| Price Target Difference | 37.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 9.34% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 20, 2015. It was a forward split with a ratio of 2.
| Last Split Date | May 20, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
SHE:002100 has an Altman Z-Score of 1.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 4 |